Skip to main content
SpringerLink
Log in

Response to letter to the editor Re: comment on “Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration”

  • Letter to the Editor (by invitation)
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Maruyama-Inoue M, Yanagi Y, Inoue T, Kadonosono K (2024) Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 262:589–599. https://doi.org/10.1007/s00417-023-06241-8

    Article  CAS  PubMed  Google Scholar 

  2. Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG, Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS (2021) Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: Post Hoc review of HAWK and HARRIER. Ophthalmology 128:1050–1059. https://doi.org/10.1016/j.ophtha.2020.11.011

    Article  PubMed  Google Scholar 

  3. Hirono K, Maruyama-Inoue M, Yanagi Y, Kadonosono K (2024) Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration. PLoS One 19:e0302295. https://doi.org/10.1371/journal.pone.0302295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-Cho, Minami-Ku, Yokohama, Kanagawa, 232-0024, Japan

    Maiko Maruyama-Inoue & Kazuaki Kadonosono

  2. National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore

    Jacob Yuhang Chin

Authors
  1. Maiko Maruyama-Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacob Yuhang Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuaki Kadonosono
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maiko Maruyama-Inoue.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maruyama-Inoue, M., Chin, J.Y. & Kadonosono, K. Response to letter to the editor Re: comment on “Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration”. Graefes Arch Clin Exp Ophthalmol (2024). https://doi.org/10.1007/s00417-024-06516-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00417-024-06516-8

Search

Navigation